Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Seers, a leading wearable artificial intelligence diagnostic monitoring company, is sharpening its commercial strategy by recruiting a veteran...
Search results for "growth years"
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence
"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this devastating question time and...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
High-Dose Vitamin D During Pregnancy Linked to Higher Childhood Memory Scores, But Experts Urge Caution
Children born to mothers who consumed high-dose vitamin D supplements during pregnancy scored higher on memory tests at...
Re-evaluating the Knife: Why Some Thyroid Cancers No Longer Require Immediate Surgery
During a routine health screening, a doctor points out a small lump on your thyroid. Additional tests deliver a jarring...
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.” Oscotec is aggressively channeling...
The Surge of Pancreatic, Colorectal, and Prostate Cancers: Is Our Changing Diet to Blame?
In South Korea, the incidence of colorectal, pancreatic, and prostate cancers has risen sharply in recent years.
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market
Celltrion announced on the 12th its acquisition of Gifrer, a French healthcare specialist with a 114-year history.